Bo‐Yeon Kim
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Bioengineering top 5%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Thyroid Cancer Diagnosis and Treatment 6
-
- Dialysis and Renal Disease Management 7
- Co-authors
- Chul‐Hee KimChan‐Hee JungJi‐Oh MokSung‐Koo KangHong-Seok KimAasif HelalDughyun ChoiSang-Hee Jung
- Journals
- Diabetes & Metabolism Journal (6 papers)Scientific Reports (4 papers)Journal of Clinical Medicine (4 papers)Journal of Diabetes Investigation (4 papers)Journal of Obesity & Metabolic Syndrome (4 papers)
- Partner nations
- South KoreaUnited StatesSaudi Arabia
In The Last Decade
Bo‐Yeon Kim
111 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 158
- Endocrinology, Diabetes and Metabolism 614
- Bioengineering 70
- Physiology 274
- Spectroscopy 168
- Cardiology and Cardiovascular Medicine 230
Countries citing papers authored by Bo‐Yeon Kim
This map shows the geographic impact of Bo‐Yeon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Yeon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Yeon Kim more than expected).
Fields of papers citing papers by Bo‐Yeon Kim
This network shows the impact of papers produced by Bo‐Yeon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Yeon Kim. The network helps show where Bo‐Yeon Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo‐Yeon Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 16 | |
| 12 | 2020 | 23 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 4 | |
| 15 | 2018 | 39 | |
| 16 | 2018 | 6 | |
| 17 | 2015 | 24 | |
| 18 | 2015 | 21 | |
| 19 | 2015 | 34 | |
| 20 | 2014 | 10 |
About Bo‐Yeon Kim
Bo‐Yeon Kim is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Pathology and Forensic Medicine, Physiology and Cardiology and Cardiovascular Medicine, having authored 121 papers that have together received 2.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Asthma and respiratory diseases (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Ophthalmology and Eye Disorders (8 papers), Dialysis and Renal Disease Management (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (614 citations), Bioengineering (70 citations), Physiology (274 citations), Spectroscopy (168 citations) and Cardiology and Cardiovascular Medicine (230 citations). Bo‐Yeon Kim has collaborated with scholars based in South Korea, United States and Saudi Arabia. Frequent co-authors include Chul‐Hee Kim, Chan‐Hee Jung, Ji‐Oh Mok, Sung‐Koo Kang, Hong-Seok Kim, Aasif Helal, Dughyun Choi, Sang-Hee Jung, Sung Koo Kang and Dae Jung Kim. Their work appears in journals such as Diabetes & Metabolism Journal, Scientific Reports, Journal of Clinical Medicine, Journal of Diabetes Investigation and Journal of Obesity & Metabolic Syndrome.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.